Free Trial

Basilea Pharmaceutica (BPMUF) News Today

Basilea Pharmaceutica logo
$61.34 0.00 (0.00%)
As of 07/10/2025

BPMUF Latest News

Basilea Pharmaceutica AG (BPMUF) - Yahoo Finance
Kepler Capital Remains a Buy on Basilea Pharmaceutica (BSLN)
Basilea provides portfolio update and outlook
Kepler Capital Sticks to Their Buy Rating for Basilea Pharmaceutica (BSLN)
Kepler Capital Keeps Their Buy Rating on Basilea Pharmaceutica (BSLN)
Innoviva enters distribution, license agreement with Basilea for Zevtera
Basilea Pharmaceutica AG (BSLN.SW)
Basilea Pharmaceutica (BSLN) Gets a Buy from Kepler Capital
Basilea Pharmaceutica AG (BPMUF)
Basilea Pharma H1 Results Down; Lifts FY24 Guidance
Basilea Pharmaceutica (BSLN) Receives a Buy from Kepler Capital
BPMUF Basilea Pharmaceutica AG
Get Basilea Pharmaceutica News Delivered to You Automatically

Sign up to receive the latest news and ratings for BPMUF and its competitors with MarketBeat's FREE daily newsletter.

BPMUF Media Mentions By Week

BPMUF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BPMUF
News Sentiment

0.64

1.00

Average
Medical
News Sentiment

BPMUF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BPMUF Articles
This Week

1

0

BPMUF Articles
Average Week

Get Basilea Pharmaceutica News Delivered to You Automatically

Sign up to receive the latest news and ratings for BPMUF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:BPMUF) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners